![]() ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. | ![]() MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. | Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2007 | Founding Date 2011 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Culver City, US HQ San Diego, US Woburn, US | Locations Konstantynów Łódzki, PL HQ | Locations Austin, US HQ Montréal, CA |
Employees | Employees 16116% increase | Employees 95 | Employees 811% decrease |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) 21.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $113.3m (FY, 2025) | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $753k (FY, 2025) | Cost of goods zł24.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $112.5m (FY, 2025) | Gross profit (zł7.2m) (FY, 2025) | Gross profit N/A |
Net income | Net income ($351.5m) (FY, 2025) | Net income (zł62.6m) (FY, 2025) | Net income N/A |

Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companyForbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View company